مدیر مدیکال

Iran has the highest incidence of cancer in the Middle East at 100 cases per 100 000
population per year, leading to 105 deaths every day. Considerable rises in the number of
cancer patients would warrant timely and abundant access to anticancer drugs which is a huge
challenge to health-care system and pharmaceutical companies, delays in delivery of
affordable medicines to cancer patients can be life-threatening.
We understood the crucial role of the pharmaceutical industry in reducing barriers to medicine
access and to improve medicine availability for the thousands of patients with cancer we
established KIMA PHARMACEUTICALS as a knowledge based Company in 2010.
We focused on Iranian cancer patients treatments needs and grew fast in a competitive market
, Today we are among market leaders in Iran. Currently we also market our products in several
neighboring countries.
Through our three operating companies we are delivering medicines by excellence in
development, manufacturing and commercialization and continue to focus on one mission
which is providing affordable, effective and safe generic products to cancer patients